Evidence map›Paper›PMID 41767079›Full record

ArticleClinical case reports2026

Two Patients With Extremely Long Type 1 Diabetes Duration With Very Few Complications and Remaining Insulin Secretion.

Åke Sjöholm, Daniel Espes

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Åke SjöholmDepartment of Internal Medicine, Division of Endocrinology and Diabetology Region Gävleborg, Gävle Hospital, University of Gävle Gävle Sweden.ORCID https://orcid.org/0000-0002-5274-9748
Daniel EspesScience for Life Laboratory Uppsala University Uppsala Sweden.ORCID https://orcid.org/0000-0001-8843-7941

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present two patients with > 80 years with type 1 diabetes (T1D), but with minor complications. Their history and risk factors are characterized as are factors conferring resilience against angiopathy. Amazingly, both had clearly detectable C-peptide. The underlying reasons for their benign phenotype could form the basis for novel treatment targets.

Indexed as

angiopathylate complicationspancreatic beta‐celltype 1 diabetes

Identifiers

PMID41767079
PMCPMC12949425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.